Logo - springer
Slogan - springer

Medicine - Radiology | EJNMMI Radiopharmacy and Chemistry (Editorial Board)

EJNMMI Radiopharmacy and Chemistry

EJNMMI Radiopharmacy and Chemistry

Editor-in-Chief: Philip H. Elsinga

ISSN: 2365-421X (electronic version)

Journal no. 41181


Philip H. Elsinga, University Medical Center Groningen, Groningen, The Netherlands

Associate Editors

Angelika Bischof Delaloye, University of Lausanne, Lausanne, Switzerland

Ignasi Carrio, Autonomous University of Barcelona, Barcelona, Spain

Editorial Board

Martin Behe, Paul Scherrer Institute, Villingen, Switzerland

Guy Bormans, University of Leuven, Leuven, Belgium

Giuseppe Carlucci, New York University Langone Health, New York, USA

Jean DaSilva, University of Montral, Montreal, Canada

Clemens Decristoforo, Medical University Innsbruck, Innsbruck, Austria

Mike Kilbourn, University of Michigan Medical School, Ann Arbor, MI, USA

Klaus Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany

Xiang-Guo Li, Turku PET Centre, Turku, Finland

Robert H. Mach, University of Pennsylvania, Philadelphia, PN, USA

Jan Passchier, Imperial College London, London, UK

Marianne Patt, Universität Leipzig, Leipzig, Germany

Ivan Penuelas, University Clinic of Navarra, Pamplona, Spain

Ana Rey, Universidad de la República, Montevideo, Uruguay

Sally Schwarz, Washington University School of Medicine, St. Louis, MO, USA

Sergio Todde, University of Milano-Bicoccia, Monza, Italy

Jun Toyohara, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan

Danielle J Vugts, VU University Medical Center, Amsterdam, The Netherlands

Read this journal online

For authors and editors

  • Aims and Scope

    Aims and Scope


    EJNMMI Radiopharmacy and Chemistry publishes new research in the field of development of new imaging and radionuclide based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight in novel concepts of imaging or radionuclide based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in from of guidelines or position papers.

  • Submit Online
  • Instructions for Authors

Alerts for this journal


Get the table of contents of every new issue published in EJNMMI Radiopharmacy and Chemistry.